Title : [Docetaxel, carboplatin plus trastuzumab as neoadjuvant setting in patients with early-stage human epidermal growth factor receptor 2 positive breast cancer: a retrospective analysis].

Pub. Date : 2021 Mar 1

PMID : 33685057






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Conclusions: TCH is an effective regimen in neoadjuvant setting for patients with HER2 positive breast cancer. thiocarbohydrazide erb-b2 receptor tyrosine kinase 2 Homo sapiens